Skip to main content

Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding. 

Refine your results

Filters
Search
Include spaces in matter number if applicable. Ex.: 182 3125
Date
Displaying 1801 - 1820 of 2685
Cases and Proceedings

General Electric Company, In the Matter of

General Electric was permitted to acquire InVision Technologies, Inc. with conditions that it divest InVision's YXLON x-ray nondestructive testing and inspection equipment to a Commission approved acquirer. According to the complaint issued with the consent order, the two firms are direct competitors in a highly concentrated market. The consent order protects competition in the United States market for specialized x-ray testing and inspection including standard x-ray cabinets; x-ray systems equipped with automated defect recognition software; and high-energy x-ray generators.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410106
Docket Number
C-4119
Cases and Proceedings

Cephalon, Inc., and CIMA Labs, Inc.

The consent order settled charges that Cephalon's proposed acquisition of Cima Labs, Inc. would allow Cephalon to continue its monopoly in the United States market for drugs that eliminate or reduce the spikes of severe pain that chronic cancer patients experience. The consent order required Cephalon to grant Barr Laboratories, Inc. a fully paid, irrevocable license to make and sell a generic version of Cephalon's breakthrough cancer pain drug, Actiq, in the United States.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410025
Cases and Proceedings

Sanofi-Synthelabo and Aventis, In the Matter of

… of Sanofi-Synthelabo and Aventis, In the Matter of The consent order settled antitrust concerns that Sanofi's proposed $64 billion acquisition of …

The consent order settled antitrust concerns that Sanofi's proposed $64 billion acquisition of Aventis would create significant overlaps in several markets for pharmaceutical products while creating the world's third largest pharmaceutical company. Under terms of the consent order, Sanofi must: 1) divest its Arixtra factor Xa inhibitor to GlaxoSmithKline, plc; 2) divest its key clinical studies for the Campto® cytotoxic colorectal cancer treatment to Pfizer, Inc. and 3) divest Aventis' contractual rights to the Estorra insomnia drug either to Sepracor, Inc. or to another Commission-approved buyer.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
041 0031
Docket Number
C-4112
Cases and Proceedings

American Air Liquide, Inc.

… American Air Liquide, Inc. American Air Liquide, Inc. L’Air Liquide was permitted to acquire Messer Griesheim …
L’Air Liquide was permitted to acquire Messer Griesheim GmbH, a leading industrial gas producer. Under terms of the order, Air Liquide is required to divest six air separation units operated by Messer in California, Texas, Louisiana, and Mississippi within six months. According to the complaint, the transaction as proposed would substantially lessen competition in the market for liquid argon, liquid oxygen and liquid nitrogen.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410020
Docket Number
C-4109
Cases and Proceedings

Bonzi Software, Inc.

… Bonzi Software, Inc. Bonzi Software, Inc. There is a related federal case . … Bonzi Software, Inc. …

There is a related federal case.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
042 3016
Displaying 1801 - 1820 of 2685
Return to top